NCT06790680View on ClinicalTrials.gov

GITMO AML/MDS-Relapse Registry Study

CompletedOBSERVATIONAL
Enrollment

859

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

August 11, 2023

Study Completion Date

May 9, 2024

Conditions
Acute Myeloid LeukaemiaMyelodysplastic Syndrome
Trial Locations (1)

40124

GITMO, Bologna

All Listed Sponsors
lead

Gruppo Italiano Trapianto di Midollo Osseo

OTHER